ABBOTT LABORATORIES Quarterly Costs and Expenses in USD from Q1 2010 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: Abbott Laboratories quarterly/annual Costs and Expenses history and growth rate from Q1 2010 to Q3 2024.
Abbott Laboratories Costs and Expenses for the quarter ending September 30, 2024 was $8.78B, a 3.3% increase year-over-year.
Abbott Laboratories Costs and Expenses for the twelve months ending September 30, 2024 was $34.5B, a 1.67% increase year-over-year.
Abbott Laboratories annual Costs and Expenses for 2023 was $33.6B, a 4.7% decline from 2022.
Abbott Laboratories annual Costs and Expenses for 2022 was $35.3B, a 1.85% increase from 2021.
Abbott Laboratories annual Costs and Expenses for 2021 was $34.7B, a 18.5% increase from 2020.

Costs and Expenses, Trailing 12 Months (USD)

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$34.5B	$8.78B	+$280M	+3.3%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-10-31
Q2 2024	$34.2B	$8.71B	+$272M	+3.22%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-07-31
Q1 2024	$34B	$8.58B	+$340M	+4.13%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-02
Q4 2023	$33.6B	$8.46B	-$326M	-3.71%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-16
Q3 2023	$34B	$8.5B	-$144M	-1.67%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-10-31
Q2 2023	$34.1B	$8.44B	-$445M	-5.01%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-07-31
Q1 2023	$34.5B	$8.24B	-$745M	-8.29%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-02
Q4 2022	$35.3B	$8.79B	-$303M	-3.33%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-16
Q3 2022	$35.6B	$8.64B	+$258M	+3.08%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-01
Q2 2022	$35.3B	$8.88B	+$50M	+0.57%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	$35.3B	$8.98B	+$636M	+7.62%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-04
Q4 2021	$34.7B	$9.09B	+$821M	+9.93%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-16
Q3 2021	$33.8B	$8.38B	+$1.02B	+13.9%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-01
Q2 2021	$32.8B	$8.83B	+$2.18B	+32.7%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-02
Q1 2021	$30.6B	$8.35B	+$1.38B	+19.8%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-03
Q4 2020	$29.3B	$8.27B	+$1.34B	+19.4%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-17
Q3 2020	$27.9B	$7.36B	+$480M	+6.98%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-03
Q2 2020	$27.4B	$6.66B	-$117M	-1.73%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-04
Q1 2020	$27.5B	$6.97B	+$172M	+2.53%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-05
Q4 2019	$27.4B	$6.93B	+$325M	+4.92%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-18
Q3 2019	$27B	$6.88B	+$217M	+3.26%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-04
Q2 2019	$26.8B	$6.77B	-$112M	-1.63%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-29
Q1 2019	$26.9B	$6.8B	+$14M	+0.21%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-04-29
Q4 2018	$26.9B	$6.6B	-$338M	-4.87%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-19
Q3 2018	$27.3B	$6.66B	+$601M	+9.92%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-10-31
Q2 2018	$26.7B	$6.89B	+$634M	+10.1%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-07-31
Q1 2018	$26B	$6.78B	+$205M	+3.12%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-01
Q4 2017	$25.8B	$6.94B	+$2.39B	+52.7%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-21
Q3 2017	$23.4B	$6.06B	+$1.66B	+37.6%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-31
Q2 2017	$21.8B	$6.25B	+$1.73B	+38.4%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-01
Q1 2017	$20B	$6.58B	+$2.22B	+50.8%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-02
Q4 2016	$17.8B	$4.54B	+$171M	+3.91%	Oct 1, 2016	Dec 31, 2016	10-K	2019-02-22
Q3 2016	$17.7B	$4.41B	-$32M	-0.72%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-02
Q2 2016	$17.7B	$4.52B	+$76M	+1.71%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-02
Q1 2016	$17.6B	$4.36B	+$74M	+1.73%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-03
Q4 2015	$17.5B	$4.37B	-$154M	-3.4%	Oct 1, 2015	Dec 31, 2015	10-K	2018-02-16
Q3 2015	$17.7B	$4.44B	+$86M	+1.98%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-03
Q2 2015	$17.6B	$4.44B	+$61M	+1.39%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-03
Q1 2015	$17.5B	$4.29B	-$103M	-2.35%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-04
Q4 2014	$17.6B	$4.53B	+$937M	+26.1%	Oct 1, 2014	Dec 31, 2014	10-K	2017-02-17
Q3 2014	$16.7B	$4.35B	-$1M	-0.02%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-05
Q2 2014	$16.7B	$4.38B	-$439M	-9.11%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-04
Q1 2014	$17.2B	$4.39B	-$373M	-7.83%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-06
Q4 2013	$17.5B	$3.59B	+$378M	+11.8%	Oct 1, 2013	Dec 31, 2013	10-K	2016-02-19
Q3 2013	$17.1B	$4.35B	-$603M	-12.2%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-06
Q2 2013	$17.7B	$4.82B	+$69.9M	+1.47%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-05
Q1 2013	$17.7B	$4.76B	-$11.5M	-0.24%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-07
Q4 2012	$17.7B	$3.21B	+$8.24B		Oct 1, 2012	Dec 31, 2012	10-K	2015-02-27
Q3 2012	$9.45B	$4.95B	-$4.27B	-46.3%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-07
Q2 2012	$13.7B	$4.75B	-$3.09B	-39.4%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-06
Q1 2012	$16.8B	$4.77B	-$2.97B	-38.3%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-08
Q4 2011	$19.8B	-$5.03B	-$13.2B	-162%	Oct 1, 2011	Dec 31, 2011	10-K	2014-02-21
Q3 2011	$32.9B	$9.22B	+$1.73B	+23.1%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-07
Q2 2011	$31.2B	$7.84B	+$623M	+8.63%	Apr 1, 2011	Jun 30, 2011	10-Q	2012-08-07
Q1 2011	$30.6B	$7.74B	+$1.51B	+24.3%	Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-08
Q4 2010	$29.1B	$8.14B			Oct 1, 2010	Dec 31, 2010	10-K	2013-02-15
Q3 2010		$7.49B			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-04
Q2 2010		$7.22B			Apr 1, 2010	Jun 30, 2010	10-Q	2011-08-04
Q1 2010		$6.23B			Jan 1, 2010	Mar 31, 2010	10-Q	2011-05-06

* An asterisk sign (*) next to the value indicates that the value is likely invalid.